Potential Opportunity worth $50 Bn Opening Up in Genomics Space - Exclusive Research by MarketsandMarkets™

Potential Opportunity worth $50 Bn Opening Up in Genomics Space - Exclusive Research by MarketsandMarkets™

PR Newswire

CHICAGO, Jan. 11, 2022

CHICAGO, Jan. 11, 2022 /PRNewswire/ --  As Genome Sequencing breaks the $1000 barrier and heads towards $500, aspiring to further reduce it to $100, its shifting D2C business model is creating $45 Bn of revenue opportunity, leading to a million terabytes of genome data by 2025.The genome sequencing market will reach $25 Bn by 2026 – intensified by COVID-19, and oncology and rare disease diagnostics coupled with pan genome studies. Adjacent markets of data storage, high performance computing (HPC), lab automation, and AI will see unlocking of a further $20 Bn.


According to MarketsandMarkets™ analysis,

Currently, businesses have low access to primary intelligence to clarify some unknowns and adjacencies in these opportunity areas –

Some of the growth problems encountered by genomics companies are:

  1. Customer prioritization and assessing unmet needs:
  2. Where to play:
  3. Building a compelling Right-to-Win (RTW):

Key uncertainties/perspectives which industry leaders seek answers to:

  1. For NGS/Genomics companies:
  2. For Companies in Adjacent markets:

Therefore, MarketsandMarkets™ has announced a first-of-its-kind Genome Sequencing Strategy-as-a-Service that will help both NGS companies and adjacent business organizations deal with specific strategic decision problems. The research and analysis is focused on high-growth, niche markets, such as AI in genomics, spatial genomics & transcriptomics, liquid biopsy, single-cell analysis, and related markets, providing a comprehensive understanding of the entire genomics ecosystem through the World's First Market Intelligence Cloud, 'KnowledgeStore'. It helps find blind spots in clients' revenue decisions because of interconnections and unknowns that impacting clients and their client's clients.

Request Free Trial

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Voltar noticias em Inglês